Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement.
Across FY2012–FY2025: $1.97B in buybacks, $1.73B in dividends.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
On March 2, 2026, Leidos, Inc. (the “Issuer”), a direct wholly-owned subsidiary of Leidos Holdings, Inc. (“Leidos”), issued and sold $600 million aggregate principal amount of 4.100% senior notes due 2029 (the “2029 Notes”) and $800 million aggregate principal amount of 5.000% senior notes due 2036 (the “2036 Notes” and, collectively with the 2029 Notes, the “Notes” and, such offering, the “Notes Offering”). The Notes Offering was made pursuant to the Issuer’s automatic shelf registration statement on Form S-3 (File No. 333-293564). The Notes were issued pursuant to an indenture, dated as of October 8, 2020 (the “October 2020 Indenture”), among the Issuer, Leidos, as a guarantor, and Citibank, N.A., as trustee (the “Trustee”), as supplemented by an officers’ certificate dated March 2, 2026.
Issuer evidence: On March 2, 2026, Leidos, Inc. (the “Issuer”), a direct wholly-owned subsidiary of Leidos Holdings, Inc. (“Leidos”), issued and sold $600 million aggregate principal amount of 4.100% senior notes due 2029 (the “2029 Notes”) and $800 million aggregate principal amount of 5.000% senior notes due 2036 (the “2036 Notes” and, collectively with the 2029 Notes, the “Notes” and, such offering, the “Notes Offering”). The Notes Offering was made pursuant to the Issuer’s automatic shelf registration statement on Form S-3 (File No. 333-293564). The Notes were issued pursuant to an indenture, dated as of October 8, 2020 (the “October 2020 Indenture”), among the Issuer, Leidos, as a guarantor, and Citibank, N.A., as trustee (the “Trustee”), as supplemented by an officers’ certificate dated March 2, 2026.
Supporting evidence: Interest is payable on the 2029 Notes semi-annually in arrears at an annual rate of 4.100% on March 15 and September 15 of each year, beginning on September 15, 2026. The 2029 Notes will mature on March 15, 2029. Interest is payable on the 2036 Notes semi-annually in arrears at an annual rate of 5.000% on March 15 and September 15 of each year, beginning on September 15, 2026. The 2036 Notes will mature on March 15, 2036.
Supporting evidence: On March 2, 2026, Leidos, Inc. (the “Issuer”), a direct wholly-owned subsidiary of Leidos Holdings, Inc. (“Leidos”), issued and sold $600 million aggregate principal amount of 4.100% senior notes due 2029 (the “2029 Notes”) and $800 million aggregate principal amount of 5.000% senior notes due 2036 (the “2036 Notes” and, collectively with the 2029 Notes, the “Notes” and, such offering, the “Notes Offering”).
Supporting evidence: On March 2, 2026, Leidos, Inc. (the “Issuer”), a direct wholly-owned subsidiary of Leidos Holdings, Inc. (“Leidos”), issued and sold $600 million aggregate principal amount of 4.100% senior notes due 2029 (the “2029 Notes”) and $800 million aggregate principal amount of 5.000% senior notes due 2036 (the “2036 Notes” and, collectively with the 2029 Notes, the “Notes” and, such offering, the “Notes Offering”). The Notes Offering was made pursuant to the Issuer’s automatic shelf registration statement on Form S-3 (File No. 333-293564). The Notes were issued pursuant to an indenture, dated as of October 8, 2020 (the “October 2020 Indenture”), among the Issuer, Leidos, as a guarantor, and Citibank, N.A., as trustee (the “Trustee”), as supplemented by an officers’ certificate dated March 2, 2026.
5.000% senior notes due 2036
Note · Leidos, Inc.
Reference: 5.000% senior notes due 2036
Active
Original principal
USD 800,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Mar 15, 2036
Last reported interest terms:
5%
Reported 2026-03-03Later filings may not restate these terms; this does not confirm they still apply.
Covenant terms for this agreement are not yet verified.
On March 2, 2026, Leidos, Inc. (the “Issuer”), a direct wholly-owned subsidiary of Leidos Holdings, Inc. (“Leidos”), issued and sold $600 million aggregate principal amount of 4.100% senior notes due 2029 (the “2029 Notes”) and $800 million aggregate principal amount of 5.000% senior notes due 2036 (the “2036 Notes” and, collectively with the 2029 Notes, the “Notes” and, such offering, the “Notes Offering”). The Notes Offering was made pursuant to the Issuer’s automatic shelf registration statement on Form S-3 (File No. 333-293564). The Notes were issued pursuant to an indenture, dated as of October 8, 2020 (the “October 2020 Indenture”), among the Issuer, Leidos, as a guarantor, and Citibank, N.A., as trustee (the “Trustee”), as supplemented by an officers’ certificate dated March 2, 2026.
Issuer evidence: On March 2, 2026, Leidos, Inc. (the “Issuer”), a direct wholly-owned subsidiary of Leidos Holdings, Inc. (“Leidos”), issued and sold $600 million aggregate principal amount of 4.100% senior notes due 2029 (the “2029 Notes”) and $800 million aggregate principal amount of 5.000% senior notes due 2036 (the “2036 Notes” and, collectively with the 2029 Notes, the “Notes” and, such offering, the “Notes Offering”). The Notes Offering was made pursuant to the Issuer’s automatic shelf registration statement on Form S-3 (File No. 333-293564). The Notes were issued pursuant to an indenture, dated as of October 8, 2020 (the “October 2020 Indenture”), among the Issuer, Leidos, as a guarantor, and Citibank, N.A., as trustee (the “Trustee”), as supplemented by an officers’ certificate dated March 2, 2026.
Supporting evidence: Interest is payable on the 2029 Notes semi-annually in arrears at an annual rate of 4.100% on March 15 and September 15 of each year, beginning on September 15, 2026. The 2029 Notes will mature on March 15, 2029. Interest is payable on the 2036 Notes semi-annually in arrears at an annual rate of 5.000% on March 15 and September 15 of each year, beginning on September 15, 2026. The 2036 Notes will mature on March 15, 2036.
Supporting evidence: On March 2, 2026, Leidos, Inc. (the “Issuer”), a direct wholly-owned subsidiary of Leidos Holdings, Inc. (“Leidos”), issued and sold $600 million aggregate principal amount of 4.100% senior notes due 2029 (the “2029 Notes”) and $800 million aggregate principal amount of 5.000% senior notes due 2036 (the “2036 Notes” and, collectively with the 2029 Notes, the “Notes” and, such offering, the “Notes Offering”).
Supporting evidence: On March 2, 2026, Leidos, Inc. (the “Issuer”), a direct wholly-owned subsidiary of Leidos Holdings, Inc. (“Leidos”), issued and sold $600 million aggregate principal amount of 4.100% senior notes due 2029 (the “2029 Notes”) and $800 million aggregate principal amount of 5.000% senior notes due 2036 (the “2036 Notes” and, collectively with the 2029 Notes, the “Notes” and, such offering, the “Notes Offering”). The Notes Offering was made pursuant to the Issuer’s automatic shelf registration statement on Form S-3 (File No. 333-293564). The Notes were issued pursuant to an indenture, dated as of October 8, 2020 (the “October 2020 Indenture”), among the Issuer, Leidos, as a guarantor, and Citibank, N.A., as trustee (the “Trustee”), as supplemented by an officers’ certificate dated March 2, 2026.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
1.20×
Peer median 1.49×
EV/EBIT
10.39×
Peer median 13.41×
P/E (TTM)
11.75×
Peer median 18.50×
Peer medians compare against the 24 similar-size Information Technology Services companies (of 80 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
Component
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
National Security and Digital Segment
$7,611,000,000
$7,365,000,000
$7,196,000,000
$6,745,000,000
—
—
—
—
Health and Civil Segment
$5,069,000,000
$5,015,000,000
$4,238,000,000
$3,945,000,000
—
—
—
—
Commercial and International Segment
$2,315,000,000
$2,252,000,000
$2,126,000,000
$1,900,000,000
—
—
—
—
Defense Systems Segment
$2,179,000,000
$2,030,000,000
$1,878,000,000
$1,806,000,000
—
—
—
—
Civil Segment
—
—
—
—
$3,157,000,000
$2,994,000,000
$2,796,000,000
$2,599,000,000
Defense Solution Segment
—
—
—
—
$8,032,000,000
$7,341,000,000
$6,300,000,000
$5,778,000,000
Health Segment
—
—
—
—
$2,548,000,000
$1,962,000,000
$1,998,000,000
$1,817,000,000
By Geography (USD)
Component
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
United States
$15,703,000,000
$15,206,000,000
$14,015,000,000
$13,098,000,000
$12,469,000,000
$11,194,000,000
$10,100,000,000
$9,265,000,000
Non Us
$1,404,000,000
$1,370,000,000
$1,324,000,000
$1,189,000,000
$1,148,000,000
$1,003,000,000
$876,000,000
$929,000,000
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
